AA
Ankur Agarwal
About Ankur Agarwal
Data last updated:
Ankur Agarwal is a Managing Director at Wellcon Animal Health Private Limited (since 2015), Director at Meek Pharma Private Limited (since 2006) and Director at Rachil Remedies Pvt Ltd (since 2014), and holds 2 more current directorships. The companies operate in Pharma, Agriculture and Financial Services. The 3 current companies with reported revenue have a combined latest revenue of ₹63.83 Cr; the largest is Wellcon Animal Health Private Limited at ₹53.37 Cr (FY 2025). Earlier, Ankur Agarwal was a Director at Safecon Pharmachemie Private Limited (2021–2022) and Director at Vitapure Pharmacare Private Limited (2021–2022) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Wellcon Animal Health Private Limited U33111UP2015PTC067989 | Managing Director | 02 Jan 2015 | 2015 | ₹53.37 Cr (FY 2025) | Active |
 Meek Pharma Private Limited U24230UR2005PTC000876 | Director | 07 Oct 2006 | 2005 | ₹7.27 Cr (FY 2025) | Active |
 Rachil Remedies Pvt Ltd U45202UP2006PTC090994 | Director | 22 May 2014 | 2006 | ₹3.19 Cr (FY 2025) | Active |
| Parthsanchi Agritech Llp ACI-1972 | Designated Partner | 19 Jul 2024 | 2024 | Active | |
| Radhashok Infratech Llp ACD-3231 | Designated Partner | 11 Oct 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Safecon Pharmachemie Private Limited U24299UP2021PTC146481 | Director | 24 May 2021 | 2021 | Strike Off | |
| Vitapure Pharmacare Private Limited U70102UP2011PTC043804 | Director | 09 Feb 2021 | 2011 | ₹13,560 (FY 2024) | Active |
| Radhashok Pharmachem Private Limited U74999UP2016PTC082915 | Director | 04 May 2016 | 2016 | ₹68.78 Cr (FY 2025) | Active |
 Safecon Lifesciences Private Limited U74999UP2016PTC083395 | Director | 21 May 2016 | 2016 | ₹87.00 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ankur Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akash Sharma | 10859681 | Wellcon Animal Health Private Limited , Meek Pharma Private Limited and 1 more | Director |
| Ashok Kumar Agarwal | 03169551 | Wellcon Animal Health Private Limited , Meek Pharma Private Limited | Director |
| Anshul Agarwal | 06885646 | Meek Pharma Private Limited , Rachil Remedies Pvt Ltd and 2 more | Director |
| Deepak Kumar Agarwal | 00917053 | Meek Pharma Private Limited | Director |
| Sachin Kumar Agrawal | 10730615 | Meek Pharma Private Limited | Director |
| Anjul Agarwal | 06897907 | Rachil Remedies Pvt Ltd | Director |
| Manoj Jain | 00717904 | Rachil Remedies Pvt Ltd | Director |
| Pran Nath Mehta | 02215443 | Rachil Remedies Pvt Ltd | Director |
| Suchita Mittal | 06898069 | Rachil Remedies Pvt Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankur Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankur Agarwal
Ankur Agarwal currently holds 5 directorships: Wellcon Animal Health Private Limited (Managing Director, since 02 Jan 2015, revenue ₹53.37 Cr (FY 2025)); Meek Pharma Private Limited (Director, since 07 Oct 2006, revenue ₹7.27 Cr (FY 2025)); Rachil Remedies Pvt Ltd (Director, since 22 May 2014, revenue ₹3.19 Cr (FY 2025)); Parthsanchi Agritech Llp (Designated Partner, since 19 Jul 2024); Radhashok Infratech Llp (Designated Partner, since 11 Oct 2023).
Ankur Agarwal was first appointed on 07 Oct 2006 as Director at Meek Pharma Private Limited. The most recent appointment on record is 19 Jul 2024 at Parthsanchi Agritech Llp.
The 3 current companies of Ankur Agarwal that report revenue have a combined latest revenue of ₹63.83 Cr: Wellcon Animal Health Private Limited ₹53.37 Cr (FY 2025); Meek Pharma Private Limited ₹7.27 Cr (FY 2025); Rachil Remedies Pvt Ltd ₹3.19 Cr (FY 2025).
Ankur Agarwal held 4 earlier board appointments: Safecon Pharmachemie Private Limited (Director, 24 May 2021 to 23 Jun 2022); Vitapure Pharmacare Private Limited (Director, 09 Feb 2021 to 23 Jun 2022); Radhashok Pharmachem Private Limited (Director, 04 May 2016 to 23 Jun 2022); Safecon Lifesciences Private Limited (Director, 21 May 2016 to 23 Jun 2022).
The current boards of Ankur Agarwal's companies include Akash Sharma (Wellcon Animal Health Private Limited), Ashok Kumar Agarwal (Wellcon Animal Health Private Limited), Anshul Agarwal (Meek Pharma Private Limited), Deepak Kumar Agarwal (Meek Pharma Private Limited), Sachin Kumar Agrawal (Meek Pharma Private Limited), Anjul Agarwal (Rachil Remedies Pvt Ltd), among others.